Health Populi

MARCH 11, 2021

[Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.

Health Policy 254

Health Policy Medicare Pharmaceuticals Life Science 254

Health Populi

JUNE 24, 2021

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? For Medicare Part B programs alone, the drug could consume one-half of the total $57 billion of medicines spending… as much as the U.S. spends on NASA.

BioTech 270

BioTech Pharmaceuticals Public Health Telehealth 270

Health Populi

JANUARY 18, 2019

As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.

BioTech 166

BioTech Medicare Medical Billing Patient Experience 166

Health Populi

OCTOBER 28, 2019

A recent study on politics and health care spending in the U.S. published by the National Bureau of Economic Research found a close link between electoral politics and Medicare: that is, between legislative processes in the U.S. Congress and healthcare spending.

Pharmaceuticals 136

Pharmaceuticals Medical Billing Medicare Mental health 136

Health Populi

MAY 8, 2019

In 2018, we saw more incentives to inspire adherence to prescription drug regimens, particularly in Medicare Part D along with increasing focus by pharmacists and providers. Just under 9% of patients across all three health plan types had over $500 in OOP costs in 2018. A cost of $125 or more yields abandonment of at least 50%.

Medicare 159

Medicare BioTech Pharmaceuticals Mental health 159

Health Populi

JUNE 18, 2020

The authors, Dr. Naci and Dr. Kesselheim, are affiliated with the London School of Economics and Brigham and Women’s Hospital in Boston, note that 1% of medicines dispensed under Medicare Part D and Medicaid accounted for nearly $1 in $3 of drug spending in each program in 2015. bn to $32.8 bn to $9.9 bn for Medicaid.

BioTech 199

BioTech Medicare Life Science Telehealth 199

Health Populi

MARCH 6, 2019

is prescription drug prices — that they’re too high, that the Federal government should negotiate to lower costs for Medicare enrollees, and that out-of-pocket costs for drugs should be limited. One of the only issues bringing people together in the U.S.

Pharmaceuticals 149

Pharmaceuticals Medicare Life Science BioTech 149